Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel for Status Epilepticus Prophylaxis Post-cardiac Arrest
NCT06401707Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- May 2024
- Primary completion
- May 2027
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perampanel in status epilepticus (SE), epilepsy, sponsored by University of California, San Francisco. Started May 2024; status: recruiting.
02
Drugs
perampanel
03
Conditions
status epilepticus (SE)epilepsy
Beyond the preview
Go deeper on NCT06401707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06401707.